Back
Rocket Pharmaceuticals Quote, Financials, Valuation and Earnings
Invest. Do Good. Get Rewarded. Just $0.25/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
34
RCKT
Rocket Pharmaceuticals
Last Price:
13.07
Seasonality Move:
13.34%
7 Day Trial
ALL ACCESS PASS
$
7
Start Investing Smarter Unlock Louis Navellier's Stock Grader for free
Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.Rocket Pharmaceuticals Price Quote
$13.07
+0.03 (+0.23%)
(Updated: November 21, 2024 at 3:05 PM ET)
Rocket Pharmaceuticals Key Stats
Sell
34
Rocket Pharmaceuticals (RCKT)
is a Sell
Day range:
$12.62 - $13.23
52-week range:
$13.39 - $32.53
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
3.78%
Volume:
1.3M
Avg. volume:
804.3K
1-year change:
-40.75%
Market cap:
$1.2B
Revenue:
$0
EPS:
$-2.75
How Much Does Rocket Pharmaceuticals Make?
Data Unavailable
Is Rocket Pharmaceuticals Growing As A Company?
Data Unavailable
Rocket Pharmaceuticals Stock Price Performance
-
Did Rocket Pharmaceuticals Stock Go Up Last Month?
Rocket Pharmaceuticals share price went down by -30.71% last month -
Did RCKT's Share Price Rise Over The Last Year?
RCKT share price fell by -40.75% over the past 1 year
What Is Rocket Pharmaceuticals 52-Week High & Low?
-
What Is Rocket Pharmaceuticals’s 52-Week High Share Price?
Rocket Pharmaceuticals has traded as high as $32.53 over the past 52 weeks -
What Is Rocket Pharmaceuticals’s 52-Week Low Share Price?
Rocket Pharmaceuticals has traded as low as $13.39 over the past 52 weeks
Rocket Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Rocket Pharmaceuticals?
-
How Much Debt Does Rocket Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Rocket Pharmaceuticals Have?
Cash and short term investments quarterly total is $235.7M -
What Is Rocket Pharmaceuticals’s Book Value Per Share?
Book value per share is 3.62
Is Rocket Pharmaceuticals Cash Flow Positive?
-
What Is RCKT Cash Flow From Operations?
Cash flow from operations (TTM) is -$192.1M -
What Is Rocket Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $3.3M -
What Is Rocket Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is $28.8M
Rocket Pharmaceuticals Return On Invested Capital
Data Unavailable
Rocket Pharmaceuticals Earnings Date & Stock Price
-
What Is Rocket Pharmaceuticals's Stock Price Today?
A single share of RCKT can be purchased today for 13.04 -
What Is Rocket Pharmaceuticals’s Stock Symbol?
Rocket Pharmaceuticals trades on the nasdaq under the ticker symbol: RCKT -
When Is Rocket Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Rocket Pharmaceuticals is scheduled on February 26, 2025 -
When Is RCKT's next ex-dividend date?
Rocket Pharmaceuticals's next ex-dividend date is November 21, 2024 -
How To Buy Rocket Pharmaceuticals Stock?
You can buy Rocket Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Rocket Pharmaceuticals Competitors
-
Who Are Rocket Pharmaceuticals's Competitors?
Below is a list of companies who compete with Rocket Pharmaceuticals or are related in some way:
Rocket Pharmaceuticals Dividend Yield
-
What Is RCKT Dividend Yield?
Rocket Pharmaceuticals’s dividend yield currently is 0% -
What Is Rocket Pharmaceuticals’s Payout Ratio?
Rocket Pharmaceuticals’s payout ratio is 0% -
When Did Rocket Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 21, 2024 -
What Is Rocket Pharmaceuticals’s Dividend Per Share?
Rocket Pharmaceuticals pays a dividend of $0.00 per share
Rocket Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 5.34% |
| Revenue: | 0% | 0% |
Analyst Recommendations
| Buy Recommendations: | 11 |
|---|---|
| Hold Recommendations: | 1 |
| Sell Recommendations: | 0 |
| Price Target: | 46.93 |
| Upside from Last Price: | 259.88% |